Update on Frontline Nivolumab/Ipilimumab Combo Demonstrates Positive OS Results in PD-L1+...

Update on Frontline Nivolumab/Ipilimumab Combo Demonstrates Positive OS Results in PD-L1+... - Targeted Oncology

- July 27, 2019

Update on Frontline Nivolumab/Ipilimumab Combo Demonstrates Positive OS Results in PD-L1+... Targeted Oncology

Nivolumab (Opdivo) in combination with a low dose of ipilimumab (Yervoy) demonstrated an improvement in overall survival (OS) compared with chemotherapy ...

Search This Blog

Lung Cancer

Update on Frontline Nivolumab/Ipilimumab Combo Demonstrates Positive OS Results in PD-L1+... - Targeted Oncology

Comments

Post a Comment

Popular posts from this blog

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago

Not An Ordinary Cough: Lung Cancer Symptoms That You Might Neglect - International Business Times

Beagles, other dogs could be used to help in early detection of lung cancers, study finds - Fox 32 Chicago